Overview of the nanoparticles instrumentation market in the life sciences sector

According to the nanoparticles instrumentation market analysis in the life sciences sector has shown that the nanoparticles instrumentation market in the life sciences sector will grow at a CAGR of more than 5% over the forecast period. With increasing spending on research and development, the market for nanoparticles instrumentation has a positive outlook during the predicted period. The global spending on R&D has shown consistent growth in the last two decades and has reached more than USD 2 trillion in 2014. With the economies of developing countries growing faster than those of developed countries, these nations are envisaged to have more life sciences research facilities being set up in the coming years. This increase in the number of research and testing facilities will propel the growth prospects for the nanoparticles instrumentation market until the end of 2020.

In this market study report, the analysts have estimated factors such as the outsourcing of the drug discovery process to impel this market’s growth prospects in the future. Recently, an increasing emphasis on R&D investments and drug discovery has led several small companies to outsource their drug discovery process to subcontract laboratories, while limiting themselves to manufacturing and marketing activities. The outsourcing of the drug discovery process has resulted in the establishment of several subcontract labs, and this trend is expected to continue during the forecast period. The emergence of subcontract laboratories has enabled many companies to outsource their drug discovery process for a mere fraction of the actual infrastructure cost. Many enterprises in the US, the UK, Japan, and Germany, are rapidly outsourcing their drug discovery process to subcontract labs which will aid in the growth of this market over the forecast period.

Segmentation by technology and analysis of the nanoparticles instrumentation market in the life sciences sector

• Microscopy
• Flow cytometry
• Ultracentrifuge

During 2015, the microscopy segment led the global nanoparticles instrumentation market in the life sciences sector and accounted for more than 58% of the market share. Factors like greater accuracy and faster response time make these microscopy instruments the primary choice, as accuracy is more important than flexibility in R&D. Also, high-resolution TEMs and scanning electron microscopes involve one of the most accurate and reliable technologies for analyzing nanoparticles of sizes less than 1.3 nm. Furthermore, the increasing adoption of nanoparticles instruments in the drug discovery process will bolster the growth prospects of this market segment by the end of 2020.

Geographical segmentation and analysis of the nanoparticles instrumentation market in the life sciences sector

• Americas
• APAC
• Europe
• MEA

The Americas led the nanoparticles instrumentation market in the life sciences sector and is expected to reach more than USD 3 billion by the end of 2020. The US is home to a large number of vendors, accounting for close to one-fifth of the overall global revenue of the market. Furthermore, the growth of this market in the Americas is also attributable to the increasing usage of high-resolution microscopes for life sciences in countries like the US and Canada. For instance, advanced microscopes such as SEMs are increasingly used for cell biology research in North America. Also, significant investments in R&D and an increasing number of biotechnology start-ups and research facilities in the US will propel this market’s growth in the Americas.

Competitive landscape and key vendors

The global nanoparticle instrumentation market in the life sciences sector is highly fragmented and is characterized by the presence of many regional and global vendors in the market. The competition among the vendors is expected to intensify during the forecast period because of the advances in nanotechnology and strategic alliances.

Top vendors in the market are 

• Agilent
• Backman Coulter
• Bruker
• HORIBA
• TSI

Other prominent vendors in the market are Asylum Research, BD Biosciences, Bio-Rad Laboratories, Carl Zeiss, Delong America, DELMIC, EMD Millipore, FEI, GE Life Sciences, Hitachi Instruments, Malvern, Micromeritics Instrument, Miltenyi Biotec, Nikon, Particle Sizing Systems, and Thermo Fisher Scientific.

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global nanoparticle instrumentation market in the life sciences sector?
• What are the key market trends impacting the growth of the global nanoparticle instrumentation market in the life sciences sector?
• What are the challenges to market growth?
• Who are the key vendors in the global nanoparticle instrumentation market in the life sciences sector?
• What are the market opportunities and threats faced by the vendors in the global nanoparticle instrumentation market in the life sciences sector?
• Trending factors influencing the market shares of the Americas, APAC, Europe, and MEA.
• What are the key outcomes of the five forces analysis of the global nanoparticle instrumentation market in the life sciences sector?

Technavio also offers customization on reports based on specific client requirement.

Related report:

• Global Laboratory Analytical Instrumentation Market - Industry Analysis 2015-2019
• Global Microscopy Device Market 2016-2020
• Global Particle Size Analyzer Market 2016-2020
• Global Scanning Electron Microscope Market 2016-2020